Answers from the Lab

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph. D. , CEO and president of Mayo Clinic Laboratories, for a conversation about quality management. Specifically, they discuss:  The benefit of investing in quality management for patients, staff, and the organization. How Mayo Cli...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph. D. , CEO and president of Mayo Clinic Laboratories.  They discuss recent business trends in diagnostics and why it is important for pathologists to stay informed about these trends. Their conversation covers:  What’s driving a r...

Sanjeev Sethi, M.D., Ph. D., explains how Mayo Clinic Laboratories' new mass spectrometry test (Mayo ID: MSMN) identifies most antigens now known to cause membranous nephropathy. Precise identification of antigens is important for optimal management of this serious kidney disease. (00:32) Would you mind telling us a little bit about yourself and your background?   (01:58) Would you give us an over...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph. D. , CEO and president of Mayo Clinic Laboratories.  They discuss Dr. Morice’s recent article in Becker’s Hospital Review, “ Nine Developments Predicted to Shape Laboratory Medicine and Diagnostics in 2025 ,” and go deeper into...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Erin Graf, Ph. D., co-director of Microbiology in the Department of Laboratory Medicine and Pathology at Mayo Clinic in Arizona, to discuss benefits of automation in the laboratory.    Topics of discussion include: Specific examples of how they are using au...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph. D. , CEO and president of Mayo Clinic Laboratories, to discuss emerging concerns about H5N1 avian influenza.  Specific topics of discussion include: Patterns of transmission and what they indicate about the potential of person-t...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph. D. , CEO and president of Mayo Clinic Laboratories, to discuss the progress of artificial intelligence (AI) and what’s next in this space. Specific topics of discussion include: What’s driving the rapid acceleration of AI advanc...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph. D. , CEO and president of Mayo Clinic Laboratories, to discuss the latest in infectious disease outbreaks.     Specific topics of discussion include: Recent trends in the spread of H5 bird flu and dengue fever.  Why it’s importa...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph. D. , CEO and president of Mayo Clinic Laboratories, to discuss how labs can enhance patient access to improve health equity. Specific topics of discussion include: Innovations creating new possibilities, such as mobile clinics,...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by genetic counselors Carrie Lahner, M.S., CGC, and April Studinski Jones, M.S., CGC, to discuss how family medical history can inform genetic testing strategies.    Specific topics of discussion include: The seven main types of genetic testing, and how clinic...

John Logan Black, M.D., explains how Mayo Clinic Laboratories' UGT1A1 tests (Mayo IDs: U1A1Q and UGTFZ ) identify genetic variants that increase the risk of potentially life-threatening reactions to irinotecan, a chemotherapy agent. (00:32) Could you give us a brief overview about your background and yourself?   (02:16) Could you explain the role of the UGT1A1 gene and its significance in the phar...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph. D. , CEO and president of Mayo Clinic Laboratories, to discuss recent outbreaks in vaccine-preventable diseases.   Specific topics of discussion include: Recent increases in outbreaks of infectious diseases, such as pertussis, m...

While confirmed cases for many respiratory illnesses are currently low, they will almost certainly spread as we move further into fall and winter. Now is the perfect time to prepare and take steps to protect yourself from everything from COVID-19 and influenza to RSV and the common cold.  In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiol...

Megan Hoenig, M.S., M.P.H., CGC, explains how Mayo Clinic Laboratories' unique hypermethylation analysis (Mayo ID: MLHPB ) provides critical adjunct information for managing Lynch syndrome. That genetic condition increases patients' risk for many kinds of cancer. Speaker 3: (00:32) Could you provide our listeners with a little bit about yourself and your background?   Speaker 3: (01:27)  Could you...

From cyberattacks to utility failures, technology disruptions are a growing risk in an increasingly digitized and automated laboratory environment. Planning for technology disruptions positions laboratories to embrace the full power of automation, artificial intelligence , and digitization while still meeting critical patient care needs during an outage.  In this episode of “Answers From the Lab,”...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Alicia Algeciras-Schimnich, Ph. D., a professor of laboratory medicine and pathology at Mayo Clinic and co-director of the Clinical Immunoassay Laboratory. They discuss Mayo Clinic’s plasma test for detecting Alzheimer’s disease and how it supports increase...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Dong Chen, M.D., Ph. D., chair of the Division of Hematopathology in the Department of Laboratory Medicine and Pathology at Mayo Clinic. They discuss rare and inherited platelet disorders and esoteric laboratory testing of hematologic disorders. Specific to...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph. D., CEO and president of Mayo Clinic Laboratories. They discuss the latest news in pathogen activity and how these viruses serve as an important reminder of the role of the public-private lab partnership. Their discussion includ...

Matthew Schultz, Ph. D., and Amy White, M.S., CGC, explain how Mayo Clinic Laboratories' unique urine assay (Mayo ID: SORD ) screens for peripheral neuropathy arising from SORD gene variants. Although recently identified, SORD -related peripheral neuropathy is fairly common. (00:31) Would you share a little bit about yourself and your background?   (01:11)  Could you provide us with an overview of...

In this episode of “Answers From the Lab,” William Morice II, M.D., Ph. D., CEO and president of Mayo Clinic Laboratories, is joined by special guest Donald Thomas, M.D., a rheumatologist and lupus researcher. They discuss how Mayo Clinic Laboratories’ suite of innovative lupus testing , offered in collaboration with Progentec Diagnostics , is enhancing the care and quality of life for patients af...

John Mills, Ph. D., and Divyanshu Dubey, M.B.B.S., explain how Mayo Clinic Laboratories' new test panel can distinguish among various potential causes of demyelinating neuropathies. Test results are important for managing these devastating autoimmune conditions. Show notes Speaker 3: (00:32)  Would you provide a little background on yourself, Dr. Mills?   Speaker 3: (01:19)  Dr. Dubey?   Speaker 3...

In this episode of “Answers From the Lab,” William Morice II, M.D., Ph. D., CEO and president of Mayo Clinic Laboratories, is joined by special guests Bernard Rubin, D.O., MPH, chief medical officer of Progentec Diagnostics, and Melissa Munroe, M.D., Ph. D., chief scientific officer and principal investigator of Progentec Diagnostics. They discuss Mayo Clinic Laboratories’ suite of innovative lupu...

Ann Moyer, M.D., Ph. D., explains how Mayo Clinic Laboratories' unique genetic tests identify patients at high risk of severe reactions to fluoropyrimidines — a type of chemotherapy drug. Test results can guide clinical decision-making for safer cancer treatment. Speaker 3: (00:32)  Would you tell us a little bit about yourself and your history with this testing?   Speaker 3: (01:25)  Would you te...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph. D., CEO and president of Mayo Clinic Laboratories, to discuss the latest advancements in Alzheimer’s disease testing and treatment. Their discussion includes: Why there is an increased focus on Alzheimer’s disease in the diagnos...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph. D., CEO and president of Mayo Clinic Laboratories. They cover current trends, pain points, and opportunities for growth in the lab and diagnostics market. Their discussion includes: Insights from Dr. Morice’s participation in an...